Med Tech Home»Papers»EVA Analysis Points to Gilead Sciences, Medicine

Sponsor This Paper

EVA Analysis Points to Gilead Sciences

Share[+] | Email
Zoom This Page Save to myLibrary Save this page Post page as Slide Download PDFUse Magnifier Tool
 [ View Slideshow ] [ Report Paper ]
If you see a loading image, please wait or try again by refreshing this page after sometime.
Note : Best viewed in FF3 or above, IE7 or above
Author: Toucalit Benton (Fellow) Reads: 1006
Pages Viewed: 1006
Upload Date: 14th-Jan-2010
Conclusion
Economic value added (EVA) enhances the quality of investment performance. Gilead Sciences (GILD) appears at the top of the list for both EVA analysis and New Low Observer as the best company to research for future investment opportunity.
 

 Other similar topics highly read
 Challenges facing the Pharmaceutical Industry
 Author: Pfizer (Fellow) Reads: 4413
 Fume Cabinet Fire Protection
 Author: Todd Lindstrom (Fellow) Reads: 1125

 Recent News Releases
15 Year-Old Creates Non-Invasive Pancreatic Cancer Detection Tool
 Published On: 21st-May-2012, Views : 322, Saved: 0 time(s)
Isansys Introduces Cloud-Based Patient Status Engine(TM)
 Published On: 21st-May-2012, Views : 296, Saved: 0 time(s)
Genetic Testing Holds Tremendous Potential in Future
 Published On: 18th-May-2012, Views : 353, Saved: 0 time(s)
View All...
Short URL: http://medical.wesrch.com/paperME1XXFCJ4QARS
Post Your Comment (To post a Comment, you must login first)
Max Input Characters 1000, Remaining input Characters
1000
 
Click our Sponsors